Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02940353 · ClinicalTrials.gov registry record · NA
The TREFOIL Concept 5 Year Clinical Investigation
A NA study of Edentulous or Failing Dentition Mandible, sponsored by Nobel Biocare.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 5
- Study locations
NCT02940353 is a NA study of Edentulous or Failing Dentition Mandible that has completed, run by Nobel Biocare. The registered enrollment target is 110 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT02940353, a NA study of Edentulous or Failing Dentition Mandible, has completed, sponsored by Nobel Biocare.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 5
- Study locations
Study Summary
Prospective, single cohort, multi-center study evaluating the TREFOIL concept for the treatment of edentulous or patients with failing mandibular dentition over 5 years. 90 patients (15 per centre) will be included. The subject population is at least 18 years old, in need of an implant restored full prosthesis providing sufficient bone in the interforaminal where a fixed restoration on three implants is regarded as an appropriate treatment solution. The components are TREFOIL treatment concept (implants and framework).
Conditions Studied
Interventions
- DEVICE TREFOIL concept
Study Locations (5)
Other
- University of Verona - Verona
- Instituto Davó, Hospital Medimar Internacional - Alicante
Washington
- Dr. Higuchi &Skinner - Spokane
Western Australia
- Branemark Centre - Perth
Santiago de Chile
- Clinica Rosenberg - Santiago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2016-04 |
| Est. Completion | 2022-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02940353
The ClinicalTrials.gov registry entry for NCT02940353 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nobel Biocare, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Edentulous or Failing Dentition Mandible appearing as the primary indexed condition, and to 1 intervention - of which TREFOIL concept is the first listed.
NCT02940353 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Other, Washington, Western Australia.
Frequently Asked Questions
What is clinical trial NCT02940353 about?
NCT02940353 is a clinical study titled "The TREFOIL Concept 5 Year Clinical Investigation". Prospective, single cohort, multi-center study evaluating the TREFOIL concept for the treatment of edentulous or patients with failing mandibular dentition over 5 years. 90 patients (15 per centre) will be included. The subject population is at least 18 years old, in need of an implant restored full...
What is the current status of trial NCT02940353?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2016-04. Estimated completion is 2022-06.
What conditions does trial NCT02940353 study?
This clinical trial studies the following conditions: Edentulous or Failing Dentition Mandible.
What interventions are being tested in trial NCT02940353?
The interventions under investigation include: TREFOIL concept (DEVICE).
Who is sponsoring clinical trial NCT02940353?
This trial is sponsored by Nobel Biocare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02940353 being conducted?
This trial has 5 study locations across Washington, Western Australia, Santiago de Chile. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.